Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Although some doctors favor starting anti-HIV treatment as soon as possible after patients
learn they are infected, it is not known if treatment for recently infected patients results
in long-term benefits or harm. The purpose of this study is to learn whether or not people
should take anti-HIV drugs when they are first infected.
Phase:
Phase 2
Details
Lead Sponsor:
AIDS Clinical Trials Group
Collaborators:
Adult AIDS Clinical Trials Group National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Lopinavir Ritonavir Tenofovir